Patients hospitalized for severe COVID-19 exhibit cardiac systolic dysfunction and small vessel disease at long-term ...

Global Hemodynamic Monitoring Market valued at $1.04 billion (2021), is set to witness a growth rate of 6% in the next 5 years. Growing cases of cardiovascular diseases, COPD and other respiratory ...

Sildenafil citrate during labor did not improve perinatal outcomes potentially related to intrapartum hypoxia despite ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

According to a study published in Angewandte Chemie, researchers at the Indian Institute of Science (IISc) created an ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Insmed stock catapulted into breakout territory early Tuesday after the biotech company hit a "home run" with its treatment for PAH.

Doctors and researchers are exploring various approaches to tackle this pervasive health issue, from new medications to dietary interventions. But what if one of the most promising treatments relies ...

Doctor of Osteopathic Medicine students, Master’s degree in biomedical sciences students, medical residents and more attend ...

Exposure to wildfire smoke drifting across the country has been linked to increased risks of heart, lung and brain problems ...

Long-haul flights promise adventure, exploration or long-awaited reunions — but they come with a cost. The human body is not ...

AgelessRx, a pioneer in longevity and telehealth solutions, announces the launch of its newest offering: Tadalafil Daily, a clinician-directed, low-dose, daily version of a well-known PDE5 inhibitor.